D.E. Shaw & Co’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.81M | Buy |
595,432
+454,884
| +324% | +$5.96M | 0.01% | 1187 |
|
|
2025
Q1 | $3.09M | Sell |
140,548
-545,823
| -80% | -$12M | ﹤0.01% | 1612 |
|
|
2024
Q4 | $18.3M | Buy |
686,371
+231,023
| +51% | +$6.17M | 0.01% | 707 |
|
|
2024
Q3 | $12.2M | Buy |
455,348
+143,872
| +46% | +$3.84M | 0.01% | 862 |
|
|
2024
Q2 | $5.61M | Sell |
311,476
-162,204
| -34% | -$2.92M | 0.01% | 1209 |
|
|
2024
Q1 | $8.64M | Buy |
473,680
+441,730
| +1,383% | +$8.06M | 0.01% | 989 |
|
|
2023
Q4 | $350K | Buy |
+31,950
| New | +$350K | ﹤0.01% | 2510 |
|
|
2023
Q2 | – | Sell |
-24,736
| Closed | -$165K | – | 3167 |
|
|
2023
Q1 | $165K | Buy |
24,736
+13,462
| +119% | +$89.8K | ﹤0.01% | 2842 |
|
|
2022
Q4 | $101K | Buy |
+11,274
| New | +$101K | ﹤0.01% | 3128 |
|
|
2021
Q4 | – | Sell |
-13,695
| Closed | -$227K | – | 4044 |
|
|
2021
Q3 | $227K | Sell |
13,695
-32,472
| -70% | -$538K | ﹤0.01% | 3194 |
|
|
2021
Q2 | $985K | Buy |
+46,167
| New | +$985K | ﹤0.01% | 2509 |
|